$HIMS 20260109 32.0 PUT$ After months of successfully navigating the decline in HIMS from its $70 peak by aggressively lowering strikes on bi-weekly cycles, the strategy has finally reached a turning point with the current position expiring ITM. While the share price has retreated more than 50% and now sits below $32, this specific outcome was a conscious choice rather than a missed management opportunity. The decision to stop rolling "down and out" marks the end of a long defensive streak that kept the portfolio cash-heavy while the underlying searched for a floor. With the stock now hovering just above a significant gap from last April, letting this CSP expire ITM serves as the bridge between a pure premium-selling strategy and a directional long play.
HIMS PUT
01-10 13:30
US20260109 32.0
SidePriceRealized P&L
Buy
Close
0.00+100.00%
Closed
Hims & Hers Health Inc.
# Trade Feed: Who is your favorite trader?

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment1

  • Top
  • Latest
  • Smart shift from defence to offence, mate. Ready for the long haul? [得意]
    Reply
    Report